The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Molecular Influenza Test Market Research Report 2025
Synopsis
Rapid molecular assays are a kind of molecular influenza diagnostic test to detect influenza virus nucleic acids in upper respiratory tract specimens with high sensitivity (90-95%) and specificity. FDA-cleared rapid molecular assays are available that produce results in approximately 15-30 minutes. Some of these rapid molecular assays are CLIA-waived for point-of-care use.
The global Molecular Influenza Test market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Molecular Influenza Test is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Molecular Influenza Test is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Molecular Influenza Test in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Molecular Influenza Test include F. Hoffmann-La Roche, Quidel Corporation, Thermo Fisher Scientific, Abbott Laboratories, Becton, Dickinson, and Company, DiaSorin and bioMérieux, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Molecular Influenza Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Influenza Test.
Report Scope
The Molecular Influenza Test market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Molecular Influenza Test market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Molecular Influenza Test companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
F. Hoffmann-La Roche
Quidel Corporation
Thermo Fisher Scientific
Abbott Laboratories
Becton, Dickinson, and Company
DiaSorin
bioMérieux
Segment by Type
RT-PCR
TMA
LAMP
NASBA
Other
Segment by Application
Hospitals
Clinical Laboratories
Other End-User
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Molecular Influenza Test companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Rapid molecular assays are a kind of molecular influenza diagnostic test to detect influenza virus nucleic acids in upper respiratory tract specimens with high sensitivity (90-95%) and specificity. FDA-cleared rapid molecular assays are available that produce results in approximately 15-30 minutes. Some of these rapid molecular assays are CLIA-waived for point-of-care use.
The global Molecular Influenza Test market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Molecular Influenza Test is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Molecular Influenza Test is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Molecular Influenza Test in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Molecular Influenza Test include F. Hoffmann-La Roche, Quidel Corporation, Thermo Fisher Scientific, Abbott Laboratories, Becton, Dickinson, and Company, DiaSorin and bioMérieux, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Molecular Influenza Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Influenza Test.
Report Scope
The Molecular Influenza Test market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Molecular Influenza Test market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Molecular Influenza Test companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
F. Hoffmann-La Roche
Quidel Corporation
Thermo Fisher Scientific
Abbott Laboratories
Becton, Dickinson, and Company
DiaSorin
bioMérieux
Segment by Type
RT-PCR
TMA
LAMP
NASBA
Other
Segment by Application
Hospitals
Clinical Laboratories
Other End-User
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Molecular Influenza Test companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Influenza Test Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 RT-PCR
1.2.3 TMA
1.2.4 LAMP
1.2.5 NASBA
1.2.6 Other
1.3 Market by Application
1.3.1 Global Molecular Influenza Test Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinical Laboratories
1.3.4 Other End-User
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Molecular Influenza Test Market Perspective (2019-2030)
2.2 Molecular Influenza Test Growth Trends by Region
2.2.1 Global Molecular Influenza Test Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Molecular Influenza Test Historic Market Size by Region (2019-2024)
2.2.3 Molecular Influenza Test Forecasted Market Size by Region (2025-2030)
2.3 Molecular Influenza Test Market Dynamics
2.3.1 Molecular Influenza Test Industry Trends
2.3.2 Molecular Influenza Test Market Drivers
2.3.3 Molecular Influenza Test Market Challenges
2.3.4 Molecular Influenza Test Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Influenza Test Players by Revenue
3.1.1 Global Top Molecular Influenza Test Players by Revenue (2019-2024)
3.1.2 Global Molecular Influenza Test Revenue Market Share by Players (2019-2024)
3.2 Global Molecular Influenza Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Molecular Influenza Test Revenue
3.4 Global Molecular Influenza Test Market Concentration Ratio
3.4.1 Global Molecular Influenza Test Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Influenza Test Revenue in 2023
3.5 Molecular Influenza Test Key Players Head office and Area Served
3.6 Key Players Molecular Influenza Test Product Solution and Service
3.7 Date of Enter into Molecular Influenza Test Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Influenza Test Breakdown Data by Type
4.1 Global Molecular Influenza Test Historic Market Size by Type (2019-2024)
4.2 Global Molecular Influenza Test Forecasted Market Size by Type (2025-2030)
5 Molecular Influenza Test Breakdown Data by Application
5.1 Global Molecular Influenza Test Historic Market Size by Application (2019-2024)
5.2 Global Molecular Influenza Test Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Molecular Influenza Test Market Size (2019-2030)
6.2 North America Molecular Influenza Test Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Molecular Influenza Test Market Size by Country (2019-2024)
6.4 North America Molecular Influenza Test Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Molecular Influenza Test Market Size (2019-2030)
7.2 Europe Molecular Influenza Test Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Molecular Influenza Test Market Size by Country (2019-2024)
7.4 Europe Molecular Influenza Test Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Molecular Influenza Test Market Size (2019-2030)
8.2 Asia-Pacific Molecular Influenza Test Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Molecular Influenza Test Market Size by Region (2019-2024)
8.4 Asia-Pacific Molecular Influenza Test Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Molecular Influenza Test Market Size (2019-2030)
9.2 Latin America Molecular Influenza Test Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Molecular Influenza Test Market Size by Country (2019-2024)
9.4 Latin America Molecular Influenza Test Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Influenza Test Market Size (2019-2030)
10.2 Middle East & Africa Molecular Influenza Test Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Molecular Influenza Test Market Size by Country (2019-2024)
10.4 Middle East & Africa Molecular Influenza Test Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Company Detail
11.1.2 F. Hoffmann-La Roche Business Overview
11.1.3 F. Hoffmann-La Roche Molecular Influenza Test Introduction
11.1.4 F. Hoffmann-La Roche Revenue in Molecular Influenza Test Business (2019-2024)
11.1.5 F. Hoffmann-La Roche Recent Development
11.2 Quidel Corporation
11.2.1 Quidel Corporation Company Detail
11.2.2 Quidel Corporation Business Overview
11.2.3 Quidel Corporation Molecular Influenza Test Introduction
11.2.4 Quidel Corporation Revenue in Molecular Influenza Test Business (2019-2024)
11.2.5 Quidel Corporation Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Molecular Influenza Test Introduction
11.3.4 Thermo Fisher Scientific Revenue in Molecular Influenza Test Business (2019-2024)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Detail
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Molecular Influenza Test Introduction
11.4.4 Abbott Laboratories Revenue in Molecular Influenza Test Business (2019-2024)
11.4.5 Abbott Laboratories Recent Development
11.5 Becton, Dickinson, and Company
11.5.1 Becton, Dickinson, and Company Company Detail
11.5.2 Becton, Dickinson, and Company Business Overview
11.5.3 Becton, Dickinson, and Company Molecular Influenza Test Introduction
11.5.4 Becton, Dickinson, and Company Revenue in Molecular Influenza Test Business (2019-2024)
11.5.5 Becton, Dickinson, and Company Recent Development
11.6 DiaSorin
11.6.1 DiaSorin Company Detail
11.6.2 DiaSorin Business Overview
11.6.3 DiaSorin Molecular Influenza Test Introduction
11.6.4 DiaSorin Revenue in Molecular Influenza Test Business (2019-2024)
11.6.5 DiaSorin Recent Development
11.7 bioMérieux
11.7.1 bioMérieux Company Detail
11.7.2 bioMérieux Business Overview
11.7.3 bioMérieux Molecular Influenza Test Introduction
11.7.4 bioMérieux Revenue in Molecular Influenza Test Business (2019-2024)
11.7.5 bioMérieux Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Molecular Influenza Test Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of RT-PCR
Table 3. Key Players of TMA
Table 4. Key Players of LAMP
Table 5. Key Players of NASBA
Table 6. Key Players of Other
Table 7. Global Molecular Influenza Test Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Molecular Influenza Test Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Molecular Influenza Test Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Molecular Influenza Test Market Share by Region (2019-2024)
Table 11. Global Molecular Influenza Test Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Molecular Influenza Test Market Share by Region (2025-2030)
Table 13. Molecular Influenza Test Market Trends
Table 14. Molecular Influenza Test Market Drivers
Table 15. Molecular Influenza Test Market Challenges
Table 16. Molecular Influenza Test Market Restraints
Table 17. Global Molecular Influenza Test Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Molecular Influenza Test Market Share by Players (2019-2024)
Table 19. Global Top Molecular Influenza Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Influenza Test as of 2023)
Table 20. Ranking of Global Top Molecular Influenza Test Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Molecular Influenza Test Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Molecular Influenza Test Product Solution and Service
Table 24. Date of Enter into Molecular Influenza Test Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Molecular Influenza Test Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Molecular Influenza Test Revenue Market Share by Type (2019-2024)
Table 28. Global Molecular Influenza Test Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Molecular Influenza Test Revenue Market Share by Type (2025-2030)
Table 30. Global Molecular Influenza Test Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Molecular Influenza Test Revenue Market Share by Application (2019-2024)
Table 32. Global Molecular Influenza Test Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Molecular Influenza Test Revenue Market Share by Application (2025-2030)
Table 34. North America Molecular Influenza Test Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Molecular Influenza Test Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Molecular Influenza Test Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Molecular Influenza Test Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Molecular Influenza Test Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Molecular Influenza Test Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Molecular Influenza Test Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Molecular Influenza Test Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Molecular Influenza Test Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Molecular Influenza Test Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Molecular Influenza Test Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Molecular Influenza Test Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Molecular Influenza Test Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Molecular Influenza Test Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Molecular Influenza Test Market Size by Country (2025-2030) & (US$ Million)
Table 49. F. Hoffmann-La Roche Company Detail
Table 50. F. Hoffmann-La Roche Business Overview
Table 51. F. Hoffmann-La Roche Molecular Influenza Test Product
Table 52. F. Hoffmann-La Roche Revenue in Molecular Influenza Test Business (2019-2024) & (US$ Million)
Table 53. F. Hoffmann-La Roche Recent Development
Table 54. Quidel Corporation Company Detail
Table 55. Quidel Corporation Business Overview
Table 56. Quidel Corporation Molecular Influenza Test Product
Table 57. Quidel Corporation Revenue in Molecular Influenza Test Business (2019-2024) & (US$ Million)
Table 58. Quidel Corporation Recent Development
Table 59. Thermo Fisher Scientific Company Detail
Table 60. Thermo Fisher Scientific Business Overview
Table 61. Thermo Fisher Scientific Molecular Influenza Test Product
Table 62. Thermo Fisher Scientific Revenue in Molecular Influenza Test Business (2019-2024) & (US$ Million)
Table 63. Thermo Fisher Scientific Recent Development
Table 64. Abbott Laboratories Company Detail
Table 65. Abbott Laboratories Business Overview
Table 66. Abbott Laboratories Molecular Influenza Test Product
Table 67. Abbott Laboratories Revenue in Molecular Influenza Test Business (2019-2024) & (US$ Million)
Table 68. Abbott Laboratories Recent Development
Table 69. Becton, Dickinson, and Company Company Detail
Table 70. Becton, Dickinson, and Company Business Overview
Table 71. Becton, Dickinson, and Company Molecular Influenza Test Product
Table 72. Becton, Dickinson, and Company Revenue in Molecular Influenza Test Business (2019-2024) & (US$ Million)
Table 73. Becton, Dickinson, and Company Recent Development
Table 74. DiaSorin Company Detail
Table 75. DiaSorin Business Overview
Table 76. DiaSorin Molecular Influenza Test Product
Table 77. DiaSorin Revenue in Molecular Influenza Test Business (2019-2024) & (US$ Million)
Table 78. DiaSorin Recent Development
Table 79. bioMérieux Company Detail
Table 80. bioMérieux Business Overview
Table 81. bioMérieux Molecular Influenza Test Product
Table 82. bioMérieux Revenue in Molecular Influenza Test Business (2019-2024) & (US$ Million)
Table 83. bioMérieux Recent Development
Table 84. Research Programs/Design for This Report
Table 85. Key Data Information from Secondary Sources
Table 86. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Molecular Influenza Test Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Molecular Influenza Test Market Share by Type: 2023 VS 2030
Figure 3. RT-PCR Features
Figure 4. TMA Features
Figure 5. LAMP Features
Figure 6. NASBA Features
Figure 7. Other Features
Figure 8. Global Molecular Influenza Test Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Molecular Influenza Test Market Share by Application: 2023 VS 2030
Figure 10. Hospitals Case Studies
Figure 11. Clinical Laboratories Case Studies
Figure 12. Other End-User Case Studies
Figure 13. Molecular Influenza Test Report Years Considered
Figure 14. Global Molecular Influenza Test Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Molecular Influenza Test Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Molecular Influenza Test Market Share by Region: 2023 VS 2030
Figure 17. Global Molecular Influenza Test Market Share by Players in 2023
Figure 18. Global Top Molecular Influenza Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Influenza Test as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Molecular Influenza Test Revenue in 2023
Figure 20. North America Molecular Influenza Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Molecular Influenza Test Market Share by Country (2019-2030)
Figure 22. United States Molecular Influenza Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Molecular Influenza Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Molecular Influenza Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Molecular Influenza Test Market Share by Country (2019-2030)
Figure 26. Germany Molecular Influenza Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Molecular Influenza Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Molecular Influenza Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Molecular Influenza Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Molecular Influenza Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Molecular Influenza Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Molecular Influenza Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Molecular Influenza Test Market Share by Region (2019-2030)
Figure 34. China Molecular Influenza Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Molecular Influenza Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Molecular Influenza Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Molecular Influenza Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Molecular Influenza Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Molecular Influenza Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Molecular Influenza Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Molecular Influenza Test Market Share by Country (2019-2030)
Figure 42. Mexico Molecular Influenza Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Molecular Influenza Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Molecular Influenza Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Molecular Influenza Test Market Share by Country (2019-2030)
Figure 46. Turkey Molecular Influenza Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Molecular Influenza Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. F. Hoffmann-La Roche Revenue Growth Rate in Molecular Influenza Test Business (2019-2024)
Figure 49. Quidel Corporation Revenue Growth Rate in Molecular Influenza Test Business (2019-2024)
Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Molecular Influenza Test Business (2019-2024)
Figure 51. Abbott Laboratories Revenue Growth Rate in Molecular Influenza Test Business (2019-2024)
Figure 52. Becton, Dickinson, and Company Revenue Growth Rate in Molecular Influenza Test Business (2019-2024)
Figure 53. DiaSorin Revenue Growth Rate in Molecular Influenza Test Business (2019-2024)
Figure 54. bioMérieux Revenue Growth Rate in Molecular Influenza Test Business (2019-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
